VM was also shown to be promoted by tumor-associated macrophages (TAMs) by increasing the expression of cyclooxygenase 2 in the tumor cells (Rong et al., 2016) and has been associated with poor patient prognosis. This evidence concerns the gene PTGS2 and neoplasm.